We retrospectively analyzed 99 cases of zoonotic dermatophytosis diagnosed by culture over a 10-year period at a dermatological clinic. Microsporum canis was the most frequently isolated species (89 cases), followed by Trichophyton verrucosum (4 cases), T. mentagrophytes (4 cases), T. benhamiae (1 case), and T. erinacei (1 case). Patients < 15 years of age accounted for 31.3% of the cases. Tinea corporis was the predominant clinical form, with frequent facial and upper-extremity involvement. Topical corticosteroid misuse was noted in 37 patients, and multiple family members were affected in 20 cases. M. canis infections were mostly linked to cats, including stray cats and adopted shelter cats. Infections caused by T. benhamiae and T. erinacei were traced to guinea pigs and hedgehogs, respectively. These findings highlight diagnostic challenges and emerging animal reservoirs. The One Health approach requires active surveillance and education across human and animal health.
{"title":"Emerging Zoonotic Dermatophytosis: A 10-Year Case Series from a Dermatology Clinic in Japan.","authors":"Yuichi Kageshita, Masahide Kubo, Hiromitsu Noguchi, Tadahiko Matsumoto, Sayaka Ohara, Daiki Hayashi, Kayo Kashiwada-Nakamura, Satoshi Fukushima, Rui Kano","doi":"10.1007/s11046-025-01013-w","DOIUrl":"10.1007/s11046-025-01013-w","url":null,"abstract":"<p><p>We retrospectively analyzed 99 cases of zoonotic dermatophytosis diagnosed by culture over a 10-year period at a dermatological clinic. Microsporum canis was the most frequently isolated species (89 cases), followed by Trichophyton verrucosum (4 cases), T. mentagrophytes (4 cases), T. benhamiae (1 case), and T. erinacei (1 case). Patients < 15 years of age accounted for 31.3% of the cases. Tinea corporis was the predominant clinical form, with frequent facial and upper-extremity involvement. Topical corticosteroid misuse was noted in 37 patients, and multiple family members were affected in 20 cases. M. canis infections were mostly linked to cats, including stray cats and adopted shelter cats. Infections caused by T. benhamiae and T. erinacei were traced to guinea pigs and hedgehogs, respectively. These findings highlight diagnostic challenges and emerging animal reservoirs. The One Health approach requires active surveillance and education across human and animal health.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"107"},"PeriodicalIF":2.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145422265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-29DOI: 10.1007/s11046-025-01017-6
Yang Wang, Lixuan Lou, Yang Cong, Chunni Huang, Yuchao Zhou, Shutian Xu, Mingzhu Zheng, Shijun Li
Introduction: Pneumocystis jirovecii pneumonia (PJP) is one of the leading causes of mortality in kidney transplant recipients. Identifying risk factors for mortality in high-risk patients is essential for developing timely and proactive treatment strategies.
Materials and methods: We conducted a retrospective analysis of clinical data from kidney transplant recipients who developed PJP progressing to acute respiratory distress syndrome. Baseline patient demographics, laboratory parameters on admission, and especially absolute lymphocyte count (ALC) levels within the first week of hospitalization were collected, along with follow-up data on patient outcomes. We analyzed ALC trajectory to define persistent lymphopenia and employed logistic regression to identify predictors of all-cause in-hospital mortality. A clinical prediction model was subsequently developed and evaluated using a range of performance metrics.
Results: Based on clinical indicators observed after admission, we defined persistent lymphopenia as an ALC below 400/μL for at least four consecutive days. In-hospital mortality was significantly higher in patients with persistent lymphopenia. Logistic regression analysis identified persistent lymphopenia, the C-reactive protein to albumin ratio, and the PaO₂/FiO₂ ratio as significant risk factors for in-hospital mortality. The clinical prediction model constructed from these variables exhibited excellent diagnostic performance and clinical applicability.
Conclusion: Persistent lymphopenia is a significant risk factor for patient mortality, and the clinical prediction model based on this factor demonstrates good diagnostic performance and clinical applicability.
{"title":"The Development of a Prediction Model for In-Hospital Mortality of Pneumocystis Jirovecii Pneumonia among Kidney Transplant Recipients Based on the Trajectory of Absolute Lymphocyte Count.","authors":"Yang Wang, Lixuan Lou, Yang Cong, Chunni Huang, Yuchao Zhou, Shutian Xu, Mingzhu Zheng, Shijun Li","doi":"10.1007/s11046-025-01017-6","DOIUrl":"10.1007/s11046-025-01017-6","url":null,"abstract":"<p><strong>Introduction: </strong>Pneumocystis jirovecii pneumonia (PJP) is one of the leading causes of mortality in kidney transplant recipients. Identifying risk factors for mortality in high-risk patients is essential for developing timely and proactive treatment strategies.</p><p><strong>Materials and methods: </strong>We conducted a retrospective analysis of clinical data from kidney transplant recipients who developed PJP progressing to acute respiratory distress syndrome. Baseline patient demographics, laboratory parameters on admission, and especially absolute lymphocyte count (ALC) levels within the first week of hospitalization were collected, along with follow-up data on patient outcomes. We analyzed ALC trajectory to define persistent lymphopenia and employed logistic regression to identify predictors of all-cause in-hospital mortality. A clinical prediction model was subsequently developed and evaluated using a range of performance metrics.</p><p><strong>Results: </strong>Based on clinical indicators observed after admission, we defined persistent lymphopenia as an ALC below 400/μL for at least four consecutive days. In-hospital mortality was significantly higher in patients with persistent lymphopenia. Logistic regression analysis identified persistent lymphopenia, the C-reactive protein to albumin ratio, and the PaO₂/FiO₂ ratio as significant risk factors for in-hospital mortality. The clinical prediction model constructed from these variables exhibited excellent diagnostic performance and clinical applicability.</p><p><strong>Conclusion: </strong>Persistent lymphopenia is a significant risk factor for patient mortality, and the clinical prediction model based on this factor demonstrates good diagnostic performance and clinical applicability.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"106"},"PeriodicalIF":2.9,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145401409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eumycetoma is a neglected tropical disease caused primarily by a Madurella mycetomatis infection, besides other related species. In this study, we designed a novel loop-mediated isothermal amplification (LAMP) primer set capable of simultaneously detecting four Madurella species (M. mycetomatis, M. pseudomycetomatis, M. tropicana, and M. fahalii). Genomic sequencing of M. pseudomycetomatis strain and comparative genome analysis revealed the candidate genes that were common among and specific to Madurella species. The 3 LAMP primer sets targeting these genes detected up to 1 pg of the genomic DNA of all 4 Madurella species, exhibiting no cross-reactivity toward other pathogenic fungi. Among these, one primer set showing better reactivity was selected as a candidate used for diagnosis. Therefore, we developed novel primer sets which enabled the simultaneous detection of four Madurella species. Our present findings will lead to a faster and simpler diagnostic tool for eumycetoma detection, especially in rural clinical settings.
足菌肿是一种被忽视的热带病,除其他相关物种外,主要由足菌马杜雷菌感染引起。在这项研究中,我们设计了一种新的环介导等温扩增(LAMP)引物,能够同时检测四种Madurella物种(M. mycetomatis, M. pseudomycetomatis, M. tropicana和M. faalii)。假omycetomatis菌株的基因组测序和比较基因组分析显示候选基因在Madurella种中是共同的和特异性的。针对这些基因的3个LAMP引物组检测到所有4种Madurella物种的基因组DNA高达1pg,与其他致病真菌无交叉反应。其中选取一组反应性较好的引物作为诊断的候选引物。因此,我们开发了新的引物集,可以同时检测四种马杜拉属植物。我们目前的发现将导致一个更快,更简单的诊断工具,为真菌肿检测,特别是在农村临床设置。
{"title":"Simultaneous Detection of Four Madurella Species Using Loop-Mediated Isothermal Amplification (LAMP) for Eumycetoma Diagnosis.","authors":"Isato Yoshioka, Ahmed Hassan Fahal, Doudou Sow, Satoshi Kaneko, Yugo Mori, Sayaka Ban, Takashi Yaguchi","doi":"10.1007/s11046-025-01019-4","DOIUrl":"10.1007/s11046-025-01019-4","url":null,"abstract":"<p><p>Eumycetoma is a neglected tropical disease caused primarily by a Madurella mycetomatis infection, besides other related species. In this study, we designed a novel loop-mediated isothermal amplification (LAMP) primer set capable of simultaneously detecting four Madurella species (M. mycetomatis, M. pseudomycetomatis, M. tropicana, and M. fahalii). Genomic sequencing of M. pseudomycetomatis strain and comparative genome analysis revealed the candidate genes that were common among and specific to Madurella species. The 3 LAMP primer sets targeting these genes detected up to 1 pg of the genomic DNA of all 4 Madurella species, exhibiting no cross-reactivity toward other pathogenic fungi. Among these, one primer set showing better reactivity was selected as a candidate used for diagnosis. Therefore, we developed novel primer sets which enabled the simultaneous detection of four Madurella species. Our present findings will lead to a faster and simpler diagnostic tool for eumycetoma detection, especially in rural clinical settings.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"105"},"PeriodicalIF":2.9,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12568910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145391596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-25DOI: 10.1007/s11046-025-01011-y
Paschalis Evangelidis, Elisavet Chorafa, Maria Kourti, Elias Pilianidis, Elias Iosifidis
Invasive fungal infections constitute a major cause of morbidity and mortality in children, affecting mainly those with malignancies and immunodeficiencies (primary or secondary), who receive solid or hematopoietic stem cell transplantation, and those in neonatal or pediatric intensive care units. Overuse and inappropriate prescription of antifungal (AF) agents have been reported in pediatrics, leading not only to an increase in adverse events and toxicities but also to the development of AF resistance. AF stewardship practices as part of broader antimicrobial stewardship programs are crucial for improving outcomes and reducing AF overuse and associated costs. This review has two main objectives: to summarize the published data on prescription patterns of AF agents in pediatrics and to describe the current state of pediatric AF stewardship programs worldwide, providing suggestions for their implementation. Given the significant burden of invasive fungal infections in vulnerable pediatric populations, identification of actions to improve AF stewardship practices in real-life clinical settings is essential.
{"title":"Antifungal Prescription and Stewardship in Pediatrics.","authors":"Paschalis Evangelidis, Elisavet Chorafa, Maria Kourti, Elias Pilianidis, Elias Iosifidis","doi":"10.1007/s11046-025-01011-y","DOIUrl":"10.1007/s11046-025-01011-y","url":null,"abstract":"<p><p>Invasive fungal infections constitute a major cause of morbidity and mortality in children, affecting mainly those with malignancies and immunodeficiencies (primary or secondary), who receive solid or hematopoietic stem cell transplantation, and those in neonatal or pediatric intensive care units. Overuse and inappropriate prescription of antifungal (AF) agents have been reported in pediatrics, leading not only to an increase in adverse events and toxicities but also to the development of AF resistance. AF stewardship practices as part of broader antimicrobial stewardship programs are crucial for improving outcomes and reducing AF overuse and associated costs. This review has two main objectives: to summarize the published data on prescription patterns of AF agents in pediatrics and to describe the current state of pediatric AF stewardship programs worldwide, providing suggestions for their implementation. Given the significant burden of invasive fungal infections in vulnerable pediatric populations, identification of actions to improve AF stewardship practices in real-life clinical settings is essential.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"103"},"PeriodicalIF":2.9,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145368403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-11DOI: 10.1007/s11046-025-01009-6
Yinggai Song, Vishnu Chaturvedi
Rationale: The antifungal armamentarium is shrinking while resistance to licensed agents rises. Historically, actinomycetes and fungi delivered nystatin, amphotericin B, griseofulvin and the echinocandin scaffold, yet plant-derived compounds-despite potent in-vitro activity-have rarely reached the clinic.
Objective: To frame the recent in-vivo success of papaya-seed essential oil against fluconazole-sensitive and -resistant Candida albicans within the broader context of plant-based antifungal discovery, and to propose rigorous criteria that can accelerate translation, especially considering varying resource settings.
Key points: Commentary on Ma et al. (Mycopathologia 190(5):1-14, 2025) showing that benzyl-isothiocyanate-rich papaya-seed oil outperforms fluconazole in a murine systemic candidiasis model without acute toxicity; Historical perspective on how soil microbes provided the first broad-spectrum antifungals; An eight-point checklist for future plant-extract studies, with essential and suggested elements to promote high-quality research across different laboratory settings.
Conclusion: Adherence to core methodological standards, along with suggested advanced analyses where feasible, will help identify promising plant-derived antifungal leads and support a more inclusive and effective discovery pipeline.
{"title":"Brief Primer on the Discovery of New Antifungal Drugs from Plant Sources.","authors":"Yinggai Song, Vishnu Chaturvedi","doi":"10.1007/s11046-025-01009-6","DOIUrl":"10.1007/s11046-025-01009-6","url":null,"abstract":"<p><strong>Rationale: </strong>The antifungal armamentarium is shrinking while resistance to licensed agents rises. Historically, actinomycetes and fungi delivered nystatin, amphotericin B, griseofulvin and the echinocandin scaffold, yet plant-derived compounds-despite potent in-vitro activity-have rarely reached the clinic.</p><p><strong>Objective: </strong>To frame the recent in-vivo success of papaya-seed essential oil against fluconazole-sensitive and -resistant Candida albicans within the broader context of plant-based antifungal discovery, and to propose rigorous criteria that can accelerate translation, especially considering varying resource settings.</p><p><strong>Key points: </strong>Commentary on Ma et al. (Mycopathologia 190(5):1-14, 2025) showing that benzyl-isothiocyanate-rich papaya-seed oil outperforms fluconazole in a murine systemic candidiasis model without acute toxicity; Historical perspective on how soil microbes provided the first broad-spectrum antifungals; An eight-point checklist for future plant-extract studies, with essential and suggested elements to promote high-quality research across different laboratory settings.</p><p><strong>Conclusion: </strong>Adherence to core methodological standards, along with suggested advanced analyses where feasible, will help identify promising plant-derived antifungal leads and support a more inclusive and effective discovery pipeline.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"102"},"PeriodicalIF":2.9,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145275324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09DOI: 10.1007/s11046-025-01001-0
Pianpian Hong, Nan Zheng, Tianqi Wei, Yuhan Zhang, Feilan Zhu, Yuping Chen, Xiaodong She, Weida Liu, Musang Liu
Aspergillus fumigatus, an opportunistic and allergenic pathogenic fungus, is responsible for a range of clinical disorders in humans, including invasive aspergillosis (IA), which can lead to severe infections in immunocompromised individuals. Unfortunately, the emergence of azole resistance has become a significant challenge in combating IA, necessitating further investigations into the underlying mechanisms of resistance. In this study, we conducted an integrated proteomic and phosphoproteomic analysis of biofilm proteins from both azole-resistant and wildtype strains of A. fumigatus under voriconazole pressure. Our proteomic analysis identified 148 upregulated and 146 downregulated proteins in the azole-resistant strains, while phosphoproteomic analysis revealed 316 upregulated phosphopeptides and 109 downregulated phosphopeptides, suggesting extensive phosphorylation modifications associated with azole resistance. Upon excluding the impact of protein changes, we identified 133 proteins with differential expression solely at the phosphorylation level, comprising 104 upregulated and 29 downregulated proteins. Functional annotation and analysis highlighted the significance of these differentially expressed phosphoproteins in cell wall integrity, filamentous growth, and high-osmolarity stress response, with 33 MAPK pathway-associated proteins displaying phosphopeptide level regulation. These findings provide valuable insights into the mechanisms behind azole resistance in A. fumigatus and offer potential new drug targets for combating this pathogenic fungus in humans.
{"title":"Proteomic and Phosphoproteomic Landscapes of Azole Resistance in Aspergillus fumigatus Biofilm Exposed to Voriconazole.","authors":"Pianpian Hong, Nan Zheng, Tianqi Wei, Yuhan Zhang, Feilan Zhu, Yuping Chen, Xiaodong She, Weida Liu, Musang Liu","doi":"10.1007/s11046-025-01001-0","DOIUrl":"10.1007/s11046-025-01001-0","url":null,"abstract":"<p><p>Aspergillus fumigatus, an opportunistic and allergenic pathogenic fungus, is responsible for a range of clinical disorders in humans, including invasive aspergillosis (IA), which can lead to severe infections in immunocompromised individuals. Unfortunately, the emergence of azole resistance has become a significant challenge in combating IA, necessitating further investigations into the underlying mechanisms of resistance. In this study, we conducted an integrated proteomic and phosphoproteomic analysis of biofilm proteins from both azole-resistant and wildtype strains of A. fumigatus under voriconazole pressure. Our proteomic analysis identified 148 upregulated and 146 downregulated proteins in the azole-resistant strains, while phosphoproteomic analysis revealed 316 upregulated phosphopeptides and 109 downregulated phosphopeptides, suggesting extensive phosphorylation modifications associated with azole resistance. Upon excluding the impact of protein changes, we identified 133 proteins with differential expression solely at the phosphorylation level, comprising 104 upregulated and 29 downregulated proteins. Functional annotation and analysis highlighted the significance of these differentially expressed phosphoproteins in cell wall integrity, filamentous growth, and high-osmolarity stress response, with 33 MAPK pathway-associated proteins displaying phosphopeptide level regulation. These findings provide valuable insights into the mechanisms behind azole resistance in A. fumigatus and offer potential new drug targets for combating this pathogenic fungus in humans.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"100"},"PeriodicalIF":2.9,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145252073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09DOI: 10.1007/s11046-025-01010-z
Haiyang He, Liuyang Cai, Yi Liu, Yusong Lin, Xingrui Zhu, Dongzhen Liu, Wanqing Liao, Xiaochun Xue, Weihua Pan
This study evaluates and compares the diagnostic and prognostic capabilities of ChatGPT-4o and DeepSeek-R1 in 56 HIV-negative talaromycosis cases. Clinical case fragments were de-identified and submitted to both models, with diagnostic accuracy and prognostic prediction rates statistically analyzed using chi-square tests, Fisher's exact tests, and logistic regression. Results showed DeepSeek-R1 achieved significantly higher diagnostic accuracy (66.1%) than ChatGPT-4o (3.6%) (χ2 = 48.2, p < 0.001), attributable to its regional data training focusing on Southeast Asia and southern China. Conversely, ChatGPT-4o demonstrated superior prognostic prediction accuracy (78.6% vs. 50.0%, p < 0.001), with 90.2% specificity for improved (survival) outcomes, while DeepSeek-R1 showed 86.7% sensitivity for mortality. Key diagnostic predictors included hilar lymphadenectasis (odds ratio [OR] = 6.8, 95% confidence interval [CI]: 2.1-22.3, P = 0.002) and chest pain (OR = 5.9, 95% CI: 1.4-25.6, P = 0.016). The findings highlight DeepSeek-R1's regional diagnostic advantage and ChatGPT-4o's prognostic utility, advocating for their collaborative use to enhance early detection and management of this neglected fungal infection in immunocompromised, non-HIV populations.
本研究评估并比较了chatgpt - 40和DeepSeek-R1在56例hiv阴性talaromylosis病例中的诊断和预后能力。临床病例片段被去识别并提交给两个模型,使用卡方检验、Fisher精确检验和逻辑回归对诊断准确性和预后预测率进行统计分析。结果显示,DeepSeek-R1的诊断准确率(66.1%)显著高于chatgpt - 40 (3.6%) (χ2 = 48.2, p
{"title":"Artificial Intelligence Driven Diagnosis and Prognosis Comparison of ChatGPT-4o and DeepSeek-R1 in HIV Negative Talaromycosis.","authors":"Haiyang He, Liuyang Cai, Yi Liu, Yusong Lin, Xingrui Zhu, Dongzhen Liu, Wanqing Liao, Xiaochun Xue, Weihua Pan","doi":"10.1007/s11046-025-01010-z","DOIUrl":"10.1007/s11046-025-01010-z","url":null,"abstract":"<p><p>This study evaluates and compares the diagnostic and prognostic capabilities of ChatGPT-4o and DeepSeek-R1 in 56 HIV-negative talaromycosis cases. Clinical case fragments were de-identified and submitted to both models, with diagnostic accuracy and prognostic prediction rates statistically analyzed using chi-square tests, Fisher's exact tests, and logistic regression. Results showed DeepSeek-R1 achieved significantly higher diagnostic accuracy (66.1%) than ChatGPT-4o (3.6%) (χ<sup>2</sup> = 48.2, p < 0.001), attributable to its regional data training focusing on Southeast Asia and southern China. Conversely, ChatGPT-4o demonstrated superior prognostic prediction accuracy (78.6% vs. 50.0%, p < 0.001), with 90.2% specificity for improved (survival) outcomes, while DeepSeek-R1 showed 86.7% sensitivity for mortality. Key diagnostic predictors included hilar lymphadenectasis (odds ratio [OR] = 6.8, 95% confidence interval [CI]: 2.1-22.3, P = 0.002) and chest pain (OR = 5.9, 95% CI: 1.4-25.6, P = 0.016). The findings highlight DeepSeek-R1's regional diagnostic advantage and ChatGPT-4o's prognostic utility, advocating for their collaborative use to enhance early detection and management of this neglected fungal infection in immunocompromised, non-HIV populations.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"101"},"PeriodicalIF":2.9,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-08DOI: 10.1007/s11046-025-01007-8
Zhiwei Long, Longzhen Lu, Guisheng Xian, Zhengtu Li, Mingkai Guo, Aguo Li, Zhenlin Guan, Feng Ye, Yan Wang
Background: Lower respiratory tract fungal infections (LRTFIs) contribute significantly to global disease burden, yet systematic research is limited. This study analyzes their disability-adjusted life year (DALY) burden, exploring trends, geographic patterns, demographic differences, driving factors, and inequalities.
Methods: Using Global Burden of Disease Study 2021 data, we analyzed global, regional, and national DALYs trends from 1990 to 2021 and forecasted burden to 2050. Decomposition analysis evaluated impacts of population growth, ageing, and epidemiological changes. We analyzed national burden inequalities using the Slope Index of Inequality and the Concentration Index.
Results: Global DALYs from LRTFIs decreased slightly from 1.32 to 1.30 million (1990-2021), with an age-standardized DALY rate (ASDR) decline from 25.86 to 16.37 per 100,000 (EAPC = - 1.52). The highest ASDRs were in low-SDI regions, particularly Central Sub-Saharan Africa (71.86 per 100,000). Zimbabwe, Lesotho, and the Central African Republic had the highest national burdens. Males and individuals over 50 had higher DALY rates. Population growth increased DALYs, while ageing and epidemiological shifts reduced then. Absolute inequality declined, but relative inequality increased. By 2050, DALYs are projected to rise to 1.78 million, though ASDR will decline to 10.37 per 100,000.
Conclusions: Despite progress, LRTFIs burden remains high in underdeveloped regions, particularly Africa. Population growth and ageing will drive future challenges, and significant global inequalities in disease burden persist.
{"title":"Global, Regional, and National Disability-Adjusted Life Years Burdens of Lower Respiratory Tract Fungal Infections, 1990-2021: A Systematic Analysis of the Global Burden of Disease Study 2021.","authors":"Zhiwei Long, Longzhen Lu, Guisheng Xian, Zhengtu Li, Mingkai Guo, Aguo Li, Zhenlin Guan, Feng Ye, Yan Wang","doi":"10.1007/s11046-025-01007-8","DOIUrl":"10.1007/s11046-025-01007-8","url":null,"abstract":"<p><strong>Background: </strong>Lower respiratory tract fungal infections (LRTFIs) contribute significantly to global disease burden, yet systematic research is limited. This study analyzes their disability-adjusted life year (DALY) burden, exploring trends, geographic patterns, demographic differences, driving factors, and inequalities.</p><p><strong>Methods: </strong>Using Global Burden of Disease Study 2021 data, we analyzed global, regional, and national DALYs trends from 1990 to 2021 and forecasted burden to 2050. Decomposition analysis evaluated impacts of population growth, ageing, and epidemiological changes. We analyzed national burden inequalities using the Slope Index of Inequality and the Concentration Index.</p><p><strong>Results: </strong>Global DALYs from LRTFIs decreased slightly from 1.32 to 1.30 million (1990-2021), with an age-standardized DALY rate (ASDR) decline from 25.86 to 16.37 per 100,000 (EAPC = - 1.52). The highest ASDRs were in low-SDI regions, particularly Central Sub-Saharan Africa (71.86 per 100,000). Zimbabwe, Lesotho, and the Central African Republic had the highest national burdens. Males and individuals over 50 had higher DALY rates. Population growth increased DALYs, while ageing and epidemiological shifts reduced then. Absolute inequality declined, but relative inequality increased. By 2050, DALYs are projected to rise to 1.78 million, though ASDR will decline to 10.37 per 100,000.</p><p><strong>Conclusions: </strong>Despite progress, LRTFIs burden remains high in underdeveloped regions, particularly Africa. Population growth and ageing will drive future challenges, and significant global inequalities in disease burden persist.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"98"},"PeriodicalIF":2.9,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-08DOI: 10.1007/s11046-025-01003-y
Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, Hanka Venselaar, Henrich van der Lee, Yinggai Song, Chao Tang, Auke W de Jong, Yingqian Kang, Paul E Verweij, G S de Hoog, Jochem B Buil
Aspergillus section Flavi comprises opportunistic pathogens such as Aspergillus flavus, posing significant health risks. Unlike A. fumigatus, where environmental selection drives widespread resistance, it is uncertain whether A. flavus develops azole resistance through a similar environmental route. This study analyzed 544 Aspergillus section Flavi isolates collected from 534 patients in Dutch hospitals (1994-2023). Calmodulin sequencing was used for molecular identification. Antifungal susceptibility testing (AFST) was performed according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. Cyp51A was sequenced and mutations were mapped onto the CYP 51 protein 3D model for azole-resistant or non-wild-type isolates. Clinical data, including azole exposure history and underlying diseases, were correlated with the resistance profiles. Of the 544 isolates, 520 were identified as A. flavus and 24 as related species, including A. tamarii (16), A. parasiticus (3), A. nomiae (2), A. pseudonomiae (2), and A. pseudocaelatus (1). Fourteen isolates from five patients were azole-resistant/non-WT, with resistance rates ranging from 0.2 to 0.8%. Resistant/non-WT isolates were associated with chronic diseases and prior clinical azole exposure. Among 10 patients with proven/probable invasive aspergillosis azole resistance was not observed. Two main Cyp51A-SNPs were found in azole-resistant isolates: Y119F and T329A. Aspergillus flavus was the dominant pathogenic species within the section Flavi with low levels of azole resistance. Distribution of resistant cases supports in host resistance selection rather than environmental selection. These findings highlight the need for further research on the ecological and molecular factors that influence resistance in A. flavus.
{"title":"No Evidence for Environmental Triazole Resistance Selection Route in Aspergillus Section Flavi, The Netherlands, 1994-2023.","authors":"Shaoqin Zhou, Sarah A Ahmed, Marlou Tehupeiory-Kooreman, Hanka Venselaar, Henrich van der Lee, Yinggai Song, Chao Tang, Auke W de Jong, Yingqian Kang, Paul E Verweij, G S de Hoog, Jochem B Buil","doi":"10.1007/s11046-025-01003-y","DOIUrl":"10.1007/s11046-025-01003-y","url":null,"abstract":"<p><p>Aspergillus section Flavi comprises opportunistic pathogens such as Aspergillus flavus, posing significant health risks. Unlike A. fumigatus, where environmental selection drives widespread resistance, it is uncertain whether A. flavus develops azole resistance through a similar environmental route. This study analyzed 544 Aspergillus section Flavi isolates collected from 534 patients in Dutch hospitals (1994-2023). Calmodulin sequencing was used for molecular identification. Antifungal susceptibility testing (AFST) was performed according to EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines. Cyp51A was sequenced and mutations were mapped onto the CYP 51 protein 3D model for azole-resistant or non-wild-type isolates. Clinical data, including azole exposure history and underlying diseases, were correlated with the resistance profiles. Of the 544 isolates, 520 were identified as A. flavus and 24 as related species, including A. tamarii (16), A. parasiticus (3), A. nomiae (2), A. pseudonomiae (2), and A. pseudocaelatus (1). Fourteen isolates from five patients were azole-resistant/non-WT, with resistance rates ranging from 0.2 to 0.8%. Resistant/non-WT isolates were associated with chronic diseases and prior clinical azole exposure. Among 10 patients with proven/probable invasive aspergillosis azole resistance was not observed. Two main Cyp51A-SNPs were found in azole-resistant isolates: Y119F and T329A. Aspergillus flavus was the dominant pathogenic species within the section Flavi with low levels of azole resistance. Distribution of resistant cases supports in host resistance selection rather than environmental selection. These findings highlight the need for further research on the ecological and molecular factors that influence resistance in A. flavus.</p>","PeriodicalId":19017,"journal":{"name":"Mycopathologia","volume":"190 6","pages":"99"},"PeriodicalIF":2.9,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}